These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32252002)

  • 21. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.
    Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF
    J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
    Uba AI; Yelekçi K
    J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
    Birgül K; Yıldırım Y; Karasulu HY; Karasulu E; Uba AI; Yelekçi K; Bekçi H; Cumaoğlu A; Kabasakal L; Yılmaz Ö; Küçükgüzel ŞG
    Eur J Med Chem; 2020 Dec; 208():112841. PubMed ID: 32998089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor.
    Wang J; Tucker LA; Stavropoulos J; Zhang Q; Wang YC; Bukofzer G; Niquette A; Meulbroek JA; Barnes DM; Shen J; Bouska J; Donawho C; Sheppard GS; Bell RL
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1838-43. PubMed ID: 18252827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.
    Addlagatta A; Matthews BW
    Protein Sci; 2006 Aug; 15(8):1842-8. PubMed ID: 16823043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiparasitic activities of novel, orally available fumagillin analogs.
    Arico-Muendel C; Centrella PA; Contonio BD; Morgan BA; O'Donovan G; Paradise CL; Skinner SR; Sluboski B; Svendsen JL; White KF; Debnath A; Gut J; Wilson N; McKerrow JH; DeRisi JL; Rosenthal PJ; Chiang PK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5128-31. PubMed ID: 19648008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
    Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
    Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
    Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
    Wang J; Sheppard GS; Lou P; Kawai M; BaMaung N; Erickson SA; Tucker-Garcia L; Park C; Bouska J; Wang YC; Frost D; Tapang P; Albert DH; Morgan SJ; Morowitz M; Shusterman S; Maris JM; Lesniewski R; Henkin J
    Cancer Res; 2003 Nov; 63(22):7861-9. PubMed ID: 14633714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
    Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
    Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes.
    Das BC; Chokkalingam P; Shareef MA; Shukla S; Das S; Saito M; Weiss LM
    J Eukaryot Microbiol; 2024; 71(5):e13036. PubMed ID: 39036929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2.
    McBride C; Cheruvallath Z; Komandla M; Tang M; Farrell P; Lawson JD; Vanderpool D; Wu Y; Dougan DR; Plonowski A; Holub C; Larson C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2779-2783. PubMed ID: 27136719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model.
    Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY
    Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of MetAP-2 inhibitors in cancer treatment.
    Yin SQ; Wang JJ; Zhang CM; Liu ZP
    Curr Med Chem; 2012; 19(7):1021-35. PubMed ID: 22229417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.
    Cheruvallath Z; Tang M; McBride C; Komandla M; Miura J; Ton-Nu T; Erikson P; Feng J; Farrell P; Lawson JD; Vanderpool D; Wu Y; Dougan DR; Plonowski A; Holub C; Larson C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2774-2778. PubMed ID: 27155900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation.
    Tucker LA; Zhang Q; Sheppard GS; Lou P; Jiang F; McKeegan E; Lesniewski R; Davidsen SK; Bell RL; Wang J
    Oncogene; 2008 Jun; 27(28):3967-76. PubMed ID: 18264137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.